Related Experiment Video
Updated: Jun 15, 2025

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
Published on: February 22, 2020
The nuclear export protein XPO1 provides a peptide ligand for natural killer cells
Matthew D Blunt1, Hayden Fisher2,3,4, Ralf B Schittenhelm5
1School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Abstract:
XPO1 (Exportin-1/CRM1) is a nuclear export protein that is frequently overexpressed in cancer and functions as a driver of oncogenesis. Currently small molecules that target XPO1 are being used in the clinic as anticancer agents. We identify XPO1 as a target for natural killer (NK) cells. Using immunopeptidomics, we have identified a peptide derived from XPO1 that can be recognized by the activating NK cell receptor KIR2DS2 in the context of human leukocyte antigen-C. The peptide can be endogenously processed and presented to activate NK cells specifically through this receptor. Although high XPO1 expression in cancer is commonly associated with a poor prognosis, we show that the outcome of specific cancers, such as hepatocellular carcinoma, can be substantially improved if there is concomitant evidence of NK cell infiltration. We thus identify XPO1 as a bona fide tumor antigen recognized by NK cells that offers an opportunity for a personalized approach to NK cell therapy for solid tumors.
Insights
Exportin-1 (XPO1) is a cancer-driving protein targeted by new therapies. Researchers found XPO1 is also a tumor antigen recognized by natural killer (NK) cells, enabling personalized NK cell therapy for solid tumors.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Exportin-1 (XPO1) is a nuclear export protein overexpressed in many cancers, contributing to oncogenesis.
- XPO1-targeting small molecules are clinically used as anticancer agents.
Purpose of the Study:
- To identify XPO1 as a target for natural killer (NK) cells.
- To investigate the mechanism of NK cell recognition of XPO1.
- To explore the therapeutic potential of targeting XPO1 in cancer immunotherapy.
Main Methods:
- Immunopeptidomics to identify tumor antigens.
- NK cell activation assays.
- Analysis of cancer patient data correlating XPO1 expression and NK cell infiltration with patient outcomes.
Main Results:
- A peptide derived from XPO1 was identified as recognizable by the activating NK cell receptor KIR2DS2.
- This XPO1-derived peptide can be endogenously processed and presented to activate NK cells via KIR2DS2.
- High XPO1 expression, while linked to poor prognosis, showed improved outcomes in hepatocellular carcinoma with NK cell infiltration.
Conclusions:
- XPO1 is a bona fide tumor antigen recognized by NK cells.
- XPO1 presents a target for developing personalized NK cell-based immunotherapies for solid tumors.
- NK cell infiltration in XPO1-expressing tumors may predict a favorable response to therapy.
More Related Videos
Related Concept Videos
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Regulation of Nuclear Protein Sorting
Nuclear Export of mRNA

